Human / Clinical Studies
The principal manufacturers of Cancell/Cantron/Protocel have stated that the mixture has been used by thousands of patients and that it is safe and effective in treating 50% to 80% of cancers. Reviewed in [1,2] The degree of effectiveness is said to vary with the type of malignancy. These findings, however, have not been published in peer-reviewed scientific journals and only testimonials and anecdotal reports have been provided. No clinical trials of Cancell/Cantron/Protocel have been reported.
References:
General Information About Vulvar Cancer
Incidence and Mortality Estimated new cases and deaths from vulvar cancer in the United States in 2011:[1] New cases: 4,340. Deaths: 940. Vulvar cancer is primarily a disease of elderly women but has been observed in premenopausal women as well. It is most commonly squamous cell carcinoma in type, though other histologic types do occur. Vulvar cancer is highly curable when diagnosed in an early stage. Survival is most dependent on the pathologic status of the inguinal nodes....
Read the General Information About Vulvar Cancer article > >
- Questionable methods of cancer management: Cancell/Entelev. CA Cancer J Clin 43 (1): 57-62, 1993 Jan-Feb.
- Cancell Alternative Cancer Treatment. . Available online. Last accessed February 8, 2011.
WebMD Public Information from the National Cancer Institute
